About Amdipharm Mercury
Amdipharm Mercury is a Healthcare company based in London (United Kingdom) founded in 2013, and was acquired by Concordia International in September 2015. A diversified portfolio of off-patent drugs is provided. Amdipharm Mercury has completed 1 acquisition, including Focus Pharmaceuticals. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified.
Company details
Amdipharm Mercury was founded in 2013 in London, United Kingdom, and is focused on legacy pharmaceutical products and orphan drugs. The company emerged from the acquisition of the AMCo group by Concordia International Corp in 2015. A broad portfolio of niche medicines is maintained and distributed through four ranges: Amdipharm, Mercury Pharma, Abcur, and Focus products.
- Headquarters London, United Kingdom
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website amcolimited.com
- Social LinkedIn X
- Acquired by Concordia International (Sep 2015)
- Investors
- Investments & Acquisitions
- Acquired byConcordia International
(Sep 2015)
Investors in Amdipharm Mercury
Amdipharm Mercury has secured backing from 1 investor. Prominent investors backing the company include Concordia International.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Distributes specialty pharmaceutical drugs to healthcare providers. | 2016 | concordiarxinternational.com | Oakville, Canada |
Investor details for Amdipharm Mercury
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Amdipharm Mercury
Amdipharm Mercury has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Focus Pharmaceuticals.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Geospatial data and aerial imagery services are provided globally. | focuspharmaceuticals.co.uk | London, United Kingdom | 2002 | Oct 2014 | •••• |
Complete acquisition details for Amdipharm Mercury
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Amdipharm Mercury
3 dated milestones of Amdipharm Mercury across 2 years, from founding to its latest funding, stage changes and deals.
- Founded Amdipharm Mercury is founded.
- Acquisition Acquires Focus Pharmaceuticals.
- Exit Acquired by Concordia International.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Amdipharm Mercury
Amdipharm Mercury was founded in 2013.
Amdipharm Mercury is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Amdipharm Mercury was founded in 2013 in London, United Kingdom, and is focused on legacy pharmaceutical products and orphan drugs. The company emerged from the acquisition of the AMCo group by Concordia International Corp in 2015. A broad portfolio of niche medicines is maintained and distributed through four ranges: Amdipharm, Mercury Pharma, Abcur, and Focus products.
Amdipharm Mercury has made 1 acquisition, including Focus Pharmaceuticals.
Amdipharm Mercury has 1 investor. Key investors include Concordia International.
Yes. Amdipharm Mercury was acquired by Concordia International in September 2015.